Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 4;77:102214. doi: 10.1016/j.coi.2022.102214

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Elsevier Ltd. All rights reserved.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

mRNA vaccines against pathogens besides SARS-CoV-2 in clinical development. The progression and current clinical stage (phase 1, 2, or 3) of mRNA-based vaccines against infectious diseases beyond SARS-CoV-2 is shown, with blue arrows representing vaccines currently under active development and blue boxes representing vaccines not under active investigation. Two influenza vaccines by Sanofi/Translate Bio (MRT-5400 and MRT-5401) have also been under phase 1 clinical evaluation but are not included as the current status is unclear.